Author

Meghana V. Trivedi

University of HoustonORCID 0000-0002-0585-5580Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:mouse· 1

Frequent Co-Authors

Aniket S. JoshiiD· 3 shared Ashok KumariD· 3 shared Meiricris Tomaz da SilvaiD· 3 shared Anh Tuan Vuong· 2 shared Anirban RoyiD· 2 shared Bin Guo· 2 shared Benny Abraham KaipparettuiD· 1 shared Cristeena Josphien· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Aniket S. JoshiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Targeting the IRE1α-XBP1 signaling axis impairs tumor growth and promotes myogenic differentiation in rhabdomyosarcoma

Tuan Anh Vuong, Aniket S. Joshi, Phuong Thi Bich Ho, Meiricris Tomaz da Silva, Bin Guo, Meghana V. Trivedi, Ashok Kumar

This study shows that inhibiting the IRE1α-XBP1 signaling pathway reduces tumor growth and promotes differentiation in rhabdomyosarcoma.

Communications Biology · May 6, 2026Peer-reviewedCancer Biology

TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma

Anh Tuan Vuong, Aniket S. Joshi, Anirban Roy, Kavya Mathukumalli, Phuong T. Ho, Raksha R. Bhat, Meiricris Tomaz da Silva, Tagari Samanta, Meghana V. Trivedi, Bin Guo, Benny Abraham Kaipparettu, Ashok Kumar

This study identifies TAK1 as a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma, showing its role in promoting proliferation and inhibiting myogenic differentiation.

Oncogene · Apr 6, 2026Peer-reviewedCancer Biology

The TWEAK/Fn14 signaling promotes skeletal muscle wasting during cancer cachexia

Meiricris Tomaz da Silva, Anirban Roy, Anh Tuan Vuong, Aniket S. Joshi, Cristeena Josphien, Meghana V. Trivedi, Sajedah M. Hindi, Vihang A. Narkar, Ashok Kumar

This study shows that inhibiting the TWEAK/Fn14 signaling reduces skeletal muscle wasting and tumor growth in cancer cachexia models.

iScience · May 30, 2025Peer-reviewedCell Biology